Lazard Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.1M Sell
16,935
-29,188
-63% -$5.38M 0.01% 725
2025
Q4
$8.12M Sell
46,123
-10,713
-19% -$1.75M 0.01% 444
2025
Q3
$7.96M Sell
56,836
-1,295
-2% -$175K 0.01% 471
2025
Q2
$7.3M Sell
58,131
-441
-0.8% -$54.9K 0.01% 627
2025
Q1
$8.01M Buy
58,572
+4,096
+8% +$586K 0.01% 540
2024
Q4
$8.33M Buy
54,476
+30,619
+128% +$5.16M 0.01% 511
2024
Q3
$4.62M Buy
23,857
+3,721
+18% +$778K 0.01% 654
2024
Q2
$4.67M Sell
20,136
-2,583
-11% -$561K 0.01% 690
2024
Q1
$4.9M Sell
22,719
-2,417
-10% -$566K 0.01% 681
2023
Q4
$6.5M Sell
25,136
-692
-3% -$170K 0.01% 640
2023
Q3
$6.64M Buy
25,828
+11,066
+75% +$2.96M 0.01% 629
2023
Q2
$4.2M Sell
14,762
-647
-4% -$193K 0.01% 738
2023
Q1
$4.28M Sell
15,409
-225
-1% -$62.3K 0.01% 761
2022
Q4
$4.33M Buy
15,634
+1,558
+11% +$440K 0.01% 748
2022
Q3
$3.76M Buy
14,076
+12,742
+955% +$2.71M 0.01% 765
2022
Q2
$271K Buy
1,334
+532
+66% +$109K ﹤0.01% 1220
2022
Q1
$168K Sell
802
-3,808
-83% -$828K ﹤0.01% 1289
2021
Q4
$1.1M Buy
4,610
+300
+7% +$77.1K ﹤0.01% 989
2021
Q3
$1.22M Buy
4,310
+4,302
+53,775% +$1.41M ﹤0.01% 1030
2021
Q2
$2K Sell
8
-57
-88% -$17.3K ﹤0.01% 1923
2021
Q1
$18K Buy
65
+7
+12% +$1.89K ﹤0.01% 1731
2020
Q4
$14K Sell
58
-1,491
-96% -$385K ﹤0.01% 1749
2020
Q3
$439K Sell
1,549
-5,895
-79% -$1.64M ﹤0.01% 880
2020
Q2
$1.99M Sell
7,444
-47,765
-87% -$14.4M ﹤0.01% 684
2020
Q1
$17.5M Sell
55,209
-6,720
-11% -$2.04M 0.03% 332
2019
Q4
$18.4M Sell
61,929
-30,907
-33% -$8.58M 0.03% 366
2019
Q3
$21.6M Buy
92,836
+1,563
+2% +$364K 0.04% 331
2019
Q2
$21.3M Sell
91,273
-224,567
-71% -$51.9M 0.03% 335
2019
Q1
$74.7M Sell
315,840
-266,887
-46% -$84M 0.12% 139
2018
Q4
$175M Sell
582,727
-6,643
-1% -$2.12M 0.32% 77
2018
Q3
$208M Sell
589,370
-98,256
-14% -$33.8M 0.34% 75
2018
Q2
$200M Sell
687,626
-125,625
-15% -$35.3M 0.35% 73
2018
Q1
$223M Buy
813,251
+77,818
+11% +$24.2M 0.38% 67
2017
Q4
$234M Sell
735,433
-46,055
-6% -$14.8M 0.4% 66
2017
Q3
$245M Buy
781,488
+224,511
+40% +$66.5M 0.44% 57
2017
Q2
$151M Buy
556,977
+167,388
+43% +$44.3M 0.28% 76
2017
Q1
$107M Buy
389,589
+388,280
+29,662% +$110M 0.2% 85
2016
Q4
$371K Sell
1,309
-210
-14% -$62.2K ﹤0.01% 753
2016
Q3
$475K Sell
1,519
-25,024
-94% -$7.41M ﹤0.01% 727
2016
Q2
$6.42M Sell
26,543
-6,672
-20% -$1.76M 0.01% 468
2016
Q1
$8.65M Sell
33,215
-9,278
-22% -$2.45M 0.02% 405
2015
Q4
$13M Buy
42,493
+9,948
+31% +$2.86M 0.03% 329
2015
Q3
$9.5M Sell
32,545
-6,919
-18% -$2.28M 0.02% 383
2015
Q2
$15.9M Sell
39,464
-3,475
-8% -$1.39M 0.03% 292
2015
Q1
$18.1M Sell
42,939
-13,914
-24% -$5.48M 0.04% 265
2014
Q4
$19.3M Buy
56,853
+1,830
+3% +$592K 0.04% 267
2014
Q3
$18.2M Buy
55,023
+16,233
+42% +$5.35M 0.04% 264
2014
Q2
$12.2M Buy
38,790
+26,673
+220% +$8.03M 0.03% 358
2014
Q1
$3.71M Sell
12,117
-8,274
-41% -$2.63M 0.01% 524
2013
Q4
$5.7M Sell
20,391
-14
-0.1% -$3.62K 0.01% 484
2013
Q3
$4.91M Hold
20,405
0.01% 495
2013
Q2
$4.39M Buy
+20,405
New +$4.36M 0.01% 514

Other funds holding BIIB